Banque de Luxembourg Investments (BLI)’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$51.5M Hold
215,489
1.54% 17
2025
Q4
$52.4M Sell
215,489
-34,798
-14% -$8.9M 1.54% 16
2025
Q3
$67.9M Sell
250,287
-39,600
-14% -$10.8M 1.98% 10
2025
Q2
$73.9M Sell
289,887
-51,500
-15% -$12.3M 2.12% 8
2025
Q1
$74.9M Buy
341,387
+15,400
+5% +$3.6M 2.27% 9
2024
Q4
$74.8M Buy
+325,987
New +$78.5M 2.03% 9

Other funds holding RMD

Banque de Luxembourg Investments (BLI)'s RMD Position: Q1 2026 in Review

Banque de Luxembourg Investments (BLI) held its ResMed (RMD) position steady in Q1 2026 at 215,489 shares worth $51.5M. The position accounts for 1.54% of the portfolio, ranked #17.

Banque de Luxembourg Investments (BLI) first reported a position in RMD in Q4 2024 and has held it in 6 quarters since. The position peaked at $74.9M in Q1 2025. 940 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Banque de Luxembourg Investments (BLI) held 215,489 shares of ResMed worth $51.5M as of Q1 2026.
  • Banque de Luxembourg Investments (BLI) left its ResMed share count unchanged in Q1 2026.
  • ResMed made up 1.54% of Banque de Luxembourg Investments (BLI)'s portfolio in Q1 2026, its #17 holding.
  • Banque de Luxembourg Investments (BLI) first reported a position in ResMed in Q4 2024 and has held it in 6 quarters since.
  • Banque de Luxembourg Investments (BLI)'s ResMed position peaked at $74.9M in Q1 2025.
  • 940 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Banque de Luxembourg Investments (BLI)'s 13F filing for Q1 2026, filed 15 May 2026.